UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053527
Receipt number R000061063
Scientific Title Questionnaire Survey on the User Experience of Sulprep and Niflec for Colonoscopy Preparation
Date of disclosure of the study information 2024/02/05
Last modified on 2024/02/03 11:44:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Questionnaire Survey on the User Experience of Sulprep and Niflec for Colonoscopy Preparation

Acronym

Questionnaire Survey on the User Experience of Sulprep and Niflec for Colonoscopy Preparation

Scientific Title

Questionnaire Survey on the User Experience of Sulprep and Niflec for Colonoscopy Preparation

Scientific Title:Acronym

Questionnaire Survey on the User Experience of Sulprep and Niflec for Colonoscopy Preparation

Region

Japan


Condition

Condition

Colonoscopy

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the effectiveness of Suprep as a pre-procedural medication for colonoscopy with the existing pre-procedural medication, Niflec.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The burden of pre-procedural preparation with Suprep compared to Niflec in surveys.

Key secondary outcomes

Ease of ingestion of the laxative, efficacy in bowel cleansing, volume of laxative and water intake, adverse events, etc., comparing Suprep and Niflec in surveys.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Individuals who are considered to require colon polyp removal surgery following Total Colonoscopy with pre-procedural preparation using Sulprep at our outpatient center, followed by a subsequent two-night hospital stay.

Participants who have provided consent for participation in the study via paper documentation.

Individuals aged 18 years and older.

Key exclusion criteria

Exclude individuals who meet any of the following criteria

Individuals with evident taste disorders.
Individuals who have difficulty responding to questionnaires.
Individuals with uncertain or unknown intake of laxatives or fluids, or those where uncertainty is anticipated.
Individuals with allergies to the ingredients of Sulprep, Nifrec, or sodium picosulfate.
Individuals unable to take the recommended dose of Sulprep.
Individuals with lesions requiring procedures such as endoscopic submucosal dissection rather than typical polypectomy or mucosal resection.
Patients with end-stage renal failure or undergoing dialysis.
Patients in whom the cecum or anastomosis could not be reached during TCS.
Patients in whom serious conditions such as advanced cancer were identified during TCS, aside from polyps suitable for removal.
Patients who experienced serious adverse events during TCS.
Patients with severe constipation planning to use methods other than the standard pre-procedural measures.
Individuals deemed inappropriate by the attending physician.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Yuta
Middle name
Last name Shibuya

Organization

Sendai city medical center Sendai open hospital

Division name

department of Gastroenteology

Zip code

983-0824

Address

5-22-1 Tsurugaya, Miyagino Ward, Sendai City, Miyagi Prefecture, Japan

TEL

0222521111

Email

you.s.together@openhp.or.jp


Public contact

Name of contact person

1st name Yuta
Middle name
Last name Shibuya

Organization

Sendai city medical center Sendai open hospital

Division name

department of Gastroenteology

Zip code

9830824

Address

5-22-1 Tsurugaya, Miyagino Ward, Sendai City, Miyagi Prefecture, Japan

TEL

0222521111

Homepage URL


Email

you.s.together@openhp.or.jp


Sponsor or person

Institute

Sendai city medical center Sendai open hospital, department of Gastroenteology, Yuta Shibuya.

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sendai city medical center Sendai open hospital

Address

5-22-1 Tsurugaya, Miyagino Ward, Sendai City, Miyagi Prefecture, Japan

Tel

0222521111

Email

k.tochikubo@openhp.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 02 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 01 Month 01 Day

Date of IRB

2024 Year 01 Month 18 Day

Anticipated trial start date

2024 Year 02 Month 01 Day

Last follow-up date

2024 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Registration of cases will conclude either upon reaching the target number of cases or upon the completion of the study period.


Management information

Registered date

2024 Year 02 Month 03 Day

Last modified on

2024 Year 02 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061063


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name